Outcomes & Endpoints

Identifying and developing improved, acceptable endpoints for use in clinical trials is a cornerstone of KRN's work. Relevant, achievable endpoints include both hard clinical outcomes and clinical outcomes assessments (COAs).

The Kidney Research Network collaborates closely with the teams in

PARASOL and Prepare-NS to advance the development of novel, FDA accepted trial endpoints.

The purpose of Prepare-NS is to develop and validate publicly available clinical outcome assessments (COAs) of fluid overload (FO) fit for drug development for a range of nephrotic syndrome (NS) inducing rare chronic kidney disorders.

Learn more about PARASOL here.